Diet, nutrition and Parkinson’s: what you need to know
Recipes & Nutrition
Author: Caithlin NgPublished: 14 May 2020
Prep: Cook: Serves:
From the benefits of a Mediterranean diet to the best foods to take medication with, we share highlights from a recent webinar on ‘Nutrition – the emerging role of diet and Parkinson’s’
Diet and nutrition have been found to play a crucial role in Parkinson’s. In a recent ‘Ending Parkinson’s Disease: Live’ webinar, Parkinson’s expert Dr Bastiaan Bloem, epidemiologist Dr Alberto Ascherio and Parkinson’s campaigner Omotola Thomas, considered how different foods can affect the risk of diagnosis, maintaining bowel health and more.
We share five key takeaways from their discussion.
1. Which foods can affect your risk of developing Parkinson’s?
Diet, said Dr Bloem, “is a really hot topic in the field
of Parkinson’s”. Alongside exercise, diet and nutrition “are the big new kids
on the block when it comes to improving symptoms, and perhaps, slowing down the
progression of the disease.”
Dr Bloem and Dr Ascherio praised the Mediterranean diet, which varies by country and region, for its potential to lower the risk of developing Parkinson’s. The Mediterranean diet is generally high in vegetables, fruits, grains, healthy fats and fish, and is typically low in meat and dairy. Such a diet is rich in nutrients and antioxidants, making it “better than the traditional Western diet”, according to Dr Ascherio.
On the other hand, Dr Bloem theorised that “a lifetime of
exposure to dairy” is associated with a higher risk of developing Parkinson’s,
likely due to the pesticides ingested by cattle from contaminated grass.
Dr Ascherio added: “I don’t think that globally, dairy products are known to be a major cause of pesticide exposure. Dairy also has other effects like reducing the level of uric acid in blood, which we found to be related to a risk of Parkinson’s disease.”
2. Could you be malnourished if you have Parkinson’s?
While Dr Bloem pointed out that a regular diet should
offer all the necessary nutrients, he did note that vitamin D and vitamin C can
be exceptions. “Many people, particularly when you age and particularly when
you’re a woman, are at risk of developing a vitamin D deficiency. There are
fascinating anecdotal reports of people taking vitamin D and experiencing
improved motor symptoms.”
Meanwhile, he explained, vitamin C supplements can help to
prevent bladder infections in Parkinson’s patients by acidifying the urine. “Bladder
infections can trigger a cascade that leads to worsening Parkinson’s symptoms.”
Dr Bloem also debunked the use of supplements like vitamin E, curcumin and Coenzyme Q190, which have been found to offer no benefits to people with Parkinson’s.
3. How can you maintain your bowel health?
Bowel problems are common in Parkinson’s patients, which
Dr Bloem said can be alleviated by drinking a lot of water and eating a diet
rich in fibres. People with Parkinson’s should see their general practitioner
for laxatives only if all else fails. “The rule is you need to have bowel
movements at least once every other day.”
Thomas added: “I have a three litre water bottle that I finish by the end of the day. It is a challenge, but I try to finish it. Because I struggle very greatly with constipation, I take three or four ounces of prune juice in the morning and that seems to help me.”
4. How should you take your Parkinson’s medication?
As food can interfere with the efficacy of levodopa
medication, Dr Bloem recommended taking levodopa at least half an hour before
or after a meal. In particular, he advised that protein intake be spread across
“For most patients, taking your medication with a protein
rich meal including dairy products and meat, can reduce gastrointestinal absorption
of your levodopa. So, you need the proteins in order to keep up your muscle
strength and avoid weight loss but try to spread the proteins over the day.”
Thomas acknowledged that this can be hard to do. She said:
“I have a struggle spreading my proteins with my levodopa because I can’t take
more than 15mg of levodopa at a time, so I’m taking it every two hours.
“That is one of those things whereby theoretically, I know what I’m supposed to do, but practically, I’m not able to.”
5. Should a dietician be part of your standard Parkinson’s care?
Yes, said Dr Bloem. “I think paying attention to the gut
is part of routine clinical care at every consultation for people with
Parkinson’s. Parkinson’s starts in the gut for many patients and slow bowel
movements are very common, impacting the efficacy of your medication and
appetite for food. It needs attention.”
While a Parkinson’s doctor or nurse can offer useful
dietary advice, Dr Bloem himself recommends that his patients see a dietician
at least once. “I think it’s part of standard care.”
Watch the full webinar:
Need to know
Dr Bastiaan Bloem is a professor of neurology and director of the Parkinson’s Centre of Excellence at Radboud University Medical Centre, the Netherlands, and co-author of ‘Ending Parkinson’s Disease: A Prescription for Action’, in which experts outline a bold plan to “prevent, advocate, care and treat” Parkinson’s.
Dr Alberto Ascherio is a professor of epidemiology and nutrition at the Harvard T. H. Chan School of Public Health, US,
Omotola Thomas was diagnosed with young-onset Parkinson’s in 2016. She is a mother, blogger, Parkinson’s campaigner and founder of ParkinStand – a platform designed to encourage people to fight Parkinson’s through physical and mental activities.
For more information about Parkinson’s and healthy eating, please visit the EPDA website.
Underwater boxing: Parkinson’s patients make a splash
Punching out Parkinson's goes from ring to pool
5 hours ago
Can over-the-counter drugs reduce risk of developing genetic Parkinson’s?
A new study suggests that regular use of non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin and ibuprofen may lower the risk of Parkinson’s associated with mutations of the LRRK2 gene – a common genetic cause of the condition. As part of the study, researchers analysed the data for 577 individuals with the LRRK2 gene mutation. They found that regular use of aspirin and ibuprofen – at least two pills per week for at least six months – was more prevalent in people who did not have Parkinson’s compared to those with the condition. Across the study, the use of NSAIDs corresponded with roughly a 66% decrease in the risk of Parkinson’s. The researchers say that “the results of this study suggest that the regular use of NSAID medication may lower the risk for Parkinson’s among LRRK2 variant carriers … for both ibuprofen and aspirin” but more research will need to be…
US hospital initiative improves on-time administration of Parkinson’s medication
Late or missed doses of Parkinson’s medication in hospitals can lead to longer stays and greater morbidity. To counteract this issue, a team of healthcare professionals in the US launched a project to improve the on-time administration of levodopa to people with Parkinson’s. As part of the initiative – published in the Journal of Parkinson’s Disease – several measures were implemented, including electronic alerts for nurses, stocking automated medication dispensing machines with carbidopa-levodopa products, reporting to nurse unit managers on timeliness of medication administration and more. Dr Martha A Nance, the project’s lead investigator, said: “This project was very rewarding for our team, because of its obvious, immediate, and important impact on patient care. “We have reason to think that timely administration of carbidopa-levodopa may be associated with shorter stays and better outcomes and satisfaction. Anecdotally, patients have reported being surprised and pleased that nurses were reminding them that medication…
Does deep brain stimulation for Parkinson’s increase the risk of dementia?
Researchers in France have found that deep brain stimulation for Parkinson’s may not increase the risk of developing dementia. As part of the study – published by the American Academy of Neurology – researchers identified 175 people with Parkinson’s and an average age of 56, who had deep brain stimulation. The individuals were assessed over a period of 10 years to determine if they had developed dementia. After one year, four individuals had developed dementia. After five years, 142 people from the original group were available for testing, 12 of whom had dementia. After 10 years, 104 people were available for testing, 31 of whom had dementia. Dr Elena Moro, author of the study, said: “These results are very encouraging for people with Parkinson’s and their families that they can take advantage of the benefits of deep brain stimulation without worrying about it increasing the likelihood of developing dementia.”